Skip to main content
Log in

Pembrolizumab

Pseudomembranous aspergillus tracheobronchitis and rhinovirus infection: case report

Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Sequeira H, et al. Pseudomembranous aspergillus tracheobronchitis as a complication of PD-L1 inhibitor therapy. Critical Care Medicine 46 (Suppl.): 301 abstr. 630, No. 1, 01 Jan 2018. Available from: URL: http://doi.org/10.1097/01.ccm.0000528645.28636.b8 [abstract] - USA

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pembrolizumab. Reactions Weekly 1686, 288 (2018). https://doi.org/10.1007/s40278-018-41351-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-018-41351-2

Navigation